Brief: Anika Therapeutics Q1 Revenue USD 40.523 Million
08/05/2024 21:06
May 08 (Reuters) - Anika Therapeutics Q1 gross profit USD 24.628 million. * Q1 pretax profit USD -4.471 million * Q1 income from operations USD -5.063 million * Q1 net income USD -4.514 million
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%